» Articles » PMID: 30342393

Effects of HIV Infection, Methamphetamine Dependence and Age on Cortical Thickness, Area and Volume

Abstract

Objective: This study examined the effects of HIV infection, methamphetamine dependence and their interaction on cortical thickness, area and volume, as well as the potential interactive effects on cortical morphometry of HIV and methamphetamine with age.

Method: T1-weighted structural images were obtained on a 3.0T General Electric MR750 scanner. Freesurfer v5.3.0 was used to derive cortical thickness, area and volume measures in thirty-four regions based on Desikan-Killiany atlas labels.

Results: Following correction for multiple statistical tests, HIV diagnosis was not significantly related to cortical thickness or area in any ROI, although smaller global cortical area and volume were seen in those with lower nadir CD4 count. HIV diagnosis, nevertheless, was associated with smaller mean cortical volumes in rostral middle frontal gyrus and in the inferior and superior parietal lobes. Methamphetamine dependence was significantly associated with thinner cortex especially in posterior cingulate gyrus, but was not associated with cortical area or volume following correction for multiple statistical tests. We found little evidence that methamphetamine dependence moderated differences in cortical area, volume or thickness for any ROI in the HIV seropositive group. Interactions with age revealed that HIV diagnosis attenuated the degree of age-related cortical thinning seen in non-infected individuals; intercepts indicated that young HIV seropositive individuals had thinner cortex than non-infected peers.

Conclusions: Methamphetamine dependence does not appear to potentiate a reduction of cortical area, volume or thickness in HIV seropositive individuals. The finding of thinner cortex in young HIV seropositive individuals and the association between CD4 nadir and global cortical area and volume argue for prioritizing early antiretroviral treatment.

Citing Articles

HIV-1 and methamphetamine co-treatment in primary human astrocytes: TAARgeting ER/UPR dysfunction.

Proulx J, Park I, Borgmann K NeuroImmune Pharm Ther. 2024; 3(2):139-154.

PMID: 39175523 PMC: 11338011. DOI: 10.1515/nipt-2023-0020.


Neurological, Behavioral, and Pathophysiological Characterization of the Co-Occurrence of Substance Use and HIV: A Narrative Review.

Vines L, Sotelo D, Giddens N, Manza P, Volkow N, Wang G Brain Sci. 2023; 13(10).

PMID: 37891847 PMC: 10605099. DOI: 10.3390/brainsci13101480.


Brain morphometric abnormalities and their associations with affective symptoms in males with methamphetamine use disorder during abstinence.

Hu X, Jiang P, Gao Y, Sun J, Zhou X, Zhang L Front Psychiatry. 2022; 13:1003889.

PMID: 36299549 PMC: 9588977. DOI: 10.3389/fpsyt.2022.1003889.


Effects of Human Immunodeficiency Virus Infection and Former Cocaine Dependence on Neuroanatomical Measures and Neurocognitive Performance.

Wakim K, Freedman E, Tivarus M, Christensen Z, Molholm S, Foxe J Neuroscience. 2022; 502:77-90.

PMID: 35963584 PMC: 9588737. DOI: 10.1016/j.neuroscience.2022.08.008.


Impairments in the Default Mode and Executive Networks in Methamphetamine Users During Short-Term Abstinence.

Gong M, Shen Y, Liang W, Zhang Z, He C, Lou M Int J Gen Med. 2022; 15:6073-6084.

PMID: 35821766 PMC: 9271316. DOI: 10.2147/IJGM.S369571.


References
1.
Kallianpur K, Kirk G, Sailasuta N, Valcour V, Shiramizu B, Nakamoto B . Regional cortical thinning associated with detectable levels of HIV DNA. Cereb Cortex. 2011; 22(9):2065-75. PMC: 3412442. DOI: 10.1093/cercor/bhr285. View

2.
Ciavatta V, Bichler E, Speigel I, Elder C, Teng S, Tyor W . In vitro and Ex vivo Neurotoxic Effects of Efavirenz are Greater than Those of Other Common Antiretrovirals. Neurochem Res. 2017; 42(11):3220-3232. DOI: 10.1007/s11064-017-2358-x. View

3.
Antinori A, Arendt G, Becker J, Brew B, Byrd D, Cherner M . Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007; 69(18):1789-99. PMC: 4472366. DOI: 10.1212/01.WNL.0000287431.88658.8b. View

4.
Moore D, Posada C, Parikh M, Arce M, Vaida F, Riggs P . HIV-infected individuals with co-occurring bipolar disorder evidence poor antiretroviral and psychiatric medication adherence. AIDS Behav. 2011; 16(8):2257-66. PMC: 3351543. DOI: 10.1007/s10461-011-0072-2. View

5.
Lemaitre H, Goldman A, Sambataro F, Verchinski B, Meyer-Lindenberg A, Weinberger D . Normal age-related brain morphometric changes: nonuniformity across cortical thickness, surface area and gray matter volume?. Neurobiol Aging. 2010; 33(3):617.e1-9. PMC: 3026893. DOI: 10.1016/j.neurobiolaging.2010.07.013. View